| Year |
Citation |
Score |
| 2024 |
Dong H, He X, Zhang L, Chen W, Lin YC, Liu SB, Wang H, Nguyen LXT, Li M, Zhu Y, Zhao D, Ghoda L, Serody J, Vincent B, Luznik L, et al. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nature Cancer. PMID 38413714 DOI: 10.1038/s43018-024-00736-x |
0.304 |
|
| 2023 |
Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, ... ... Serody JS, et al. Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors. Journal of Immunology (Baltimore, Md. : 1950). PMID 37204246 DOI: 10.4049/jimmunol.2300077 |
0.564 |
|
| 2023 |
Routh ED, Woodcock MG, Beckabir W, Vensko SP, Serody JS, Vincent BG. Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal For Immunotherapy of Cancer. 11. PMID 36882226 DOI: 10.1136/jitc-2022-005848 |
0.603 |
|
| 2023 |
Larson JH, Jin S, Loschi M, Wagers SB, Thangavelu G, Zaiken MC, McDonald-Hyman C, Saha A, Aguilar EG, Koehn B, Osborn MJ, Panoskaltsis-Mortari A, Macdonald KPA, Hill GR, Murphy WJ, ... Serody JS, et al. Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 36878433 DOI: 10.1016/j.ajt.2023.01.030 |
0.409 |
|
| 2022 |
Zaiken MC, Flynn R, Paz KG, Rhee SY, Jin S, Mohamed FA, Saha A, Thangavelu G, Park PMC, Hemming ML, Sage PT, Sharpe AH, DuPage M, Bluestone JA, Panoskaltsis-Mortari A, ... ... Serody JS, et al. BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood. PMID 35226736 DOI: 10.1182/blood.2021014557 |
0.33 |
|
| 2022 |
Anders CK, Woodcock MG, Van Swearingen AED, Moore DT, Sambade MJ, Laurie S, Robeson A, Kolupaev O, Cuaboy LA, Garrett AL, McKinnon K, Cowens K, Bortone D, Calhoun BC, Wilkinson AD, ... ... Serody JS, et al. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal For Immunotherapy of Cancer. 10. PMID 35121644 DOI: 10.1136/jitc-2021-003427 |
0.644 |
|
| 2022 |
Downs-Canner SM, Meier J, Vincent BG, Serody JS. B Cell Function in the Tumor Microenvironment. Annual Review of Immunology. PMID 35044794 DOI: 10.1146/annurev-immunol-101220-015603 |
0.656 |
|
| 2021 |
Zeidner JF, Vincent BG, Ivanova A, Moore D, McKinnon KP, Wilkinson AD, Mukhopadhyay R, Mazziotta F, Knaus HA, Foster MC, Coombs CC, Jamieson K, Van Deventer H, Webster JA, Prince GT, ... ... Serody JS, et al. Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Blood Cancer Discovery. 2: 616-629. PMID 34778801 DOI: 10.1158/2643-3230.BCD-21-0070 |
0.617 |
|
| 2021 |
Voorhees TJ, Zhao B, Oldan J, Hucks GE, Khandani A, Dittus C, Smith J, Morrison JK, Cheng C, Ivanova A, Park SI, Shea T, Beaven AW, Dotti G, Serody J, et al. Pretherapy metabolic tumor volume associates with response to CD30 CAR T cells in Hodgkin lymphoma. Blood Advances. PMID 34666347 DOI: 10.1182/bloodadvances.2021005385 |
0.319 |
|
| 2021 |
Bruce DW, Kolupaev OV, Laurie SJ, Bommiasamy H, Stefanski H, Blazar BR, Coghill J, Serody J. Third Party Type 2 Innate Lymphoid Cells Prevent and Treat GI Tract GvHD. Blood Advances. PMID 34619767 DOI: 10.1182/bloodadvances.2020001514 |
0.384 |
|
| 2021 |
Tschernia NP, Kumar V, Moore DT, Vincent BG, Coombs CC, Van Deventer H, Foster MC, DeZern AE, Luznik L, Riches ML, Serody JS, Gojo I, Zeidner JF. Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplant in Acute Myeloid Leukemia. Transplantation and Cellular Therapy. PMID 34474164 DOI: 10.1016/j.jtct.2021.08.022 |
0.597 |
|
| 2021 |
Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ. Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. PMID 33580223 DOI: 10.1038/s41565-021-00864-w |
0.545 |
|
| 2021 |
Xu N, Palmer DC, Robeson AC, Shou P, Bommiasamy H, Laurie SJ, Willis C, Dotti G, Vincent BG, Restifo NP, Serody JS. STING agonist promotes CAR T cell trafficking and persistence in breast cancer. The Journal of Experimental Medicine. 218. PMID 33382402 DOI: 10.1084/jem.20200844 |
0.693 |
|
| 2020 |
Voorhees TJ, Ghosh N, Grover N, Block J, Cheng C, Morrison K, Ivanova A, Dotti G, Serody J, Savoldo B, Beaven AW. Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy. Blood Advances. 4: 5925-5928. PMID 33259598 DOI: 10.1182/bloodadvances.2020003218 |
0.321 |
|
| 2020 |
Thangavelu G, Wang C, Loschi M, Saha A, Osborn M, Furlan SN, Aoyama K, McDonald-Hyman C, Aguilar EG, Janesick AS, Chandraratna RA, Refaeli Y, Panoskaltsis-Mortari A, MacDonald KP, Hill GR, ... ... Serody J, et al. Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses. Blood. PMID 32976550 DOI: 10.1182/blood.2020005628 |
0.452 |
|
| 2020 |
Ramos CA, Grover NS, Beaven AW, Lulla PD, Wu MF, Ivanova A, Wang T, Shea TC, Rooney CM, Dittus C, Park SI, Gee AP, Eldridge PW, McKay KL, Mehta B, ... ... Serody JS, et al. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001342. PMID 32701411 DOI: 10.1200/Jco.20.01342 |
0.447 |
|
| 2020 |
Judge SJ, Dunai C, Aguilar EG, Vick SC, Sturgill IR, Khuat LT, Stoffel KM, Van Dyke J, Longo DL, Darrow MA, Anderson SK, Blazar BR, Monjazeb AM, Serody JS, Canter RJ, et al. Minimal PD-1 expression in mouse and human NK cells under diverse conditions. The Journal of Clinical Investigation. PMID 32134744 DOI: 10.1172/Jci133353 |
0.424 |
|
| 2020 |
Zhu J, Patel T, Miller JA, Torrice CD, Aggarwal M, Sketch MR, Alexander MD, Armistead PM, Coghill JM, Grgic T, Jamieson KJ, Ptachcinski JR, Riches ML, Serody JS, Schmitz JL, et al. Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International Journal of Molecular Sciences. 21. PMID 32013193 DOI: 10.3390/Ijms21030858 |
0.634 |
|
| 2020 |
Mi Y, Smith CC, Serody JS, Vincent BG, Wang AZ, Hyun H. Abstract 2866: Neoantigen nanovaccine improves personalized cancer immunotherapy Cancer Research. 80: 2866-2866. DOI: 10.1158/1538-7445.Am2020-2866 |
0.376 |
|
| 2019 |
Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD. Blood. PMID 31880771 DOI: 10.1182/Blood.2019001696 |
0.7 |
|
| 2019 |
Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D, Ford J, Liu S, Vick SC, Martin M, Parker JS, ... ... Serody JS, et al. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 179: 1191-1206.e21. PMID 31730857 DOI: 10.1016/J.Cell.2019.10.028 |
0.694 |
|
| 2019 |
Thangavelu G, Du J, Paz KG, Loschi M, Zaiken MC, Flynn R, Taylor PA, Kirchmeier AK, Panoskaltsis-Mortari A, Luznik L, MacDonald KP, Hill GR, Maillard I, Munn DH, Serody JS, et al. Inhibition of Inositol kinase B controls acute and chronic graft-versus-host disease. Blood. PMID 31697815 DOI: 10.1182/Blood.2019000032 |
0.469 |
|
| 2019 |
Saha A, Taylor PA, Lees CJ, Panoskaltsis-Mortari A, Osborn MJ, Feser CJ, Thangavelu G, Melchinger W, Refaeli Y, Hill GR, Munn DH, Murphy WJ, Serody JS, Maillard I, Kreymborg K, et al. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality. Jci Insight. 4. PMID 31578305 DOI: 10.1172/Jci.Insight.127716 |
0.452 |
|
| 2019 |
Koehn BH, Saha A, McDonald-Hyman C, Loschi M, Thangavelu G, Ma L, Zaiken M, Dysthe J, Krepps W, Panthera J, Hippen K, Jameson SC, Miller JS, Cooper MA, Farady CJ, ... ... Serody JS, et al. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GvHD. Blood. PMID 31533918 DOI: 10.1182/Blood.2019001950 |
0.551 |
|
| 2019 |
Smith CC, Chai S, Washington AR, Lee SJ, Landoni E, Field K, Garness J, Bixby LM, Selitsky SR, Parker JS, Savoldo B, Serody JS, Vincent BG. Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes. Cancer Immunology Research. PMID 31515258 DOI: 10.1158/2326-6066.Cir-19-0155 |
0.793 |
|
| 2019 |
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Serody JS, et al. The Immune Landscape of Cancer. Immunity. 51: 411-412. PMID 31433971 DOI: 10.1016/J.Immuni.2019.08.004 |
0.563 |
|
| 2019 |
Smith CC, Selitsky SR, Chai S, Armistead PM, Vincent BG, Serody JS. Alternative tumour-specific antigens. Nature Reviews. Cancer. PMID 31278396 DOI: 10.1038/S41568-019-0162-4 |
0.769 |
|
| 2019 |
Thangavelu G, Lee YC, Loschi M, Schaechter KM, Feser CJ, Koehn BH, Nowak EC, Zeiser R, Serody JS, Murphy WJ, Munn DH, Chambon P, Noelle RJ, Blazar BR. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. Journal of Immunology (Baltimore, Md. : 1950). PMID 30885956 DOI: 10.4049/Jimmunol.1800899 |
0.44 |
|
| 2019 |
Paz K, Flynn R, Du J, Tannheimer S, Johnson AJ, Dong S, Stark AK, Okkenhaug K, Panoskaltsis-Mortari A, Sage PT, Sharpe AH, Luznik L, Ritz J, Soiffer RJ, Cutler CS, ... ... Serody JS, et al. Targeting PI3Kδ Function For Amelioration of Murine Chronic Graft-Versus-Host Disease. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 30748099 DOI: 10.1111/Ajt.15305 |
0.509 |
|
| 2019 |
Bruce DW, Kolupaev O, Bommiasamy H, Stefanski H, Blazar BR, Coghill JM, Serody JS. Third Party Type 2 Innate Lymphoid Cells Treat and Prevent GI Tract Acute GvHD Blood. 134: 3205-3205. DOI: 10.1182/Blood-2019-126848 |
0.506 |
|
| 2019 |
Laurie SJ, Bruce DW, Bommiasamy H, Noel MP, Foster JP, Davis IJ, Pattenden SG, Serody JS. Epigenetic Plasticity of Type II Innate Lymphoid Cells in the Lower Gastrointestinal Tract Blood. 134: 1921-1921. DOI: 10.1182/Blood-2019-126823 |
0.412 |
|
| 2019 |
Zeidner JF, Vincent BG, Esparza S, Ivanova A, Moore DT, Foster MC, Coombs CC, Jamieson K, Van Deventer HW, Blanchard L, Churchwell W, Frank C, Gallagher S, Matson M, Reed A, ... ... Serody JS, et al. Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AML Blood. 134: 831-831. DOI: 10.1182/Blood-2019-126065 |
0.347 |
|
| 2019 |
Voorhees TJ, Grover NS, Beaven A, Park SI, Morrison JK, Cheng CJA, Laing S, Dotti G, Savoldo B, Serody JS. Retrospective Cohort Study Analyzing the Safety and Efficacy of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma Blood. 134: 3233-3233. DOI: 10.1182/Blood-2019-122846 |
0.347 |
|
| 2019 |
Thorsson V, Gibbs DL, Disis ML, Demicco EG, Lazar AJ, Serody JS, Eddy JA, Shmulevich I, Guinney J, Vincent BG. Abstract 1184: Comprehensive analysis with interactive exploration of immune response signatures in 10,000 tumor samples Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1184 |
0.307 |
|
| 2019 |
Kasow KA, Brondon JE, Armistead PM, Serody JS, Vincent BG, Wood WA, Shea TC, Riches ML. Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients Biology of Blood and Marrow Transplantation. 25: S128-S129. DOI: 10.1016/J.Bbmt.2018.12.412 |
0.402 |
|
| 2019 |
Grover NS, Park SI, Ivanova A, Eldridge P, McKay K, Cheng C, Laing S, Covington D, West J, Sharf E, Morrison JK, Scott S, Crecelius E, Shelley D, Alexander M, ... ... Serody JS, et al. A Phase Ib/II Study of Anti-CD30 Chimeric Antigen Receptor T Cells for Relapsed/Refractory CD30+ Lymphomas Biology of Blood and Marrow Transplantation. 25: S66. DOI: 10.1016/J.Bbmt.2018.12.149 |
0.342 |
|
| 2018 |
Paz K, Flynn R, Du J, Qi J, Luznik L, Maillard I, MacDonald KP, Hill GR, Serody JS, Murphy WJ, Sage PT, Sharpe AH, Miklos D, Culter CS, Koreth J, et al. Small-molecule BCL6 inhibitor effectively treats mice with non-sclerodermatous chronic graft-versus-host disease. Blood. PMID 30279226 DOI: 10.1182/Blood-2018-03-839993 |
0.463 |
|
| 2018 |
Davis JM, Ivanova A, Chung Y, Shaw JR, Rao K, Sharf JP, Serody J, Armistead P, Wood WA, Coghill J, Jamieson K, Vincent BG, Riches M, Shea T, Alexander M. Evaluation of a Test Dose Strategy for Pharmacokinetically-guided Busulfan Dosing for Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30244102 DOI: 10.1016/J.Bbmt.2018.09.017 |
0.59 |
|
| 2018 |
Kolupaev OV, Dant TA, Bommiasamy H, Bruce DW, Fowler KA, Tilley SL, McKinnon KP, Sarantopoulos S, Blazar BR, Coghill JM, Serody JS. Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD. Blood Advances. 2: 2307-2319. PMID 30228128 DOI: 10.1182/Bloodadvances.2017014977 |
0.53 |
|
| 2018 |
Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, ... Serody JS, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476 |
0.811 |
|
| 2018 |
Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. Jci Insight. 3. PMID 30135306 DOI: 10.1172/Jci.Insight.121522 |
0.806 |
|
| 2018 |
McDonald-Hyman C, Muller JT, Loschi M, Thangavelu G, Saha A, Kumari S, Reichenbach DK, Smith MJ, Zhang G, Koehn BH, Lin J, Mitchell JS, Fife BT, Panoskaltsis-Mortari A, Feser CJ, ... ... Serody JS, et al. The vimentin intermediate filament network restrains regulatory T-cell suppression of graft-versus-host disease. The Journal of Clinical Investigation. PMID 30106752 DOI: 10.1172/Jci95713 |
0.5 |
|
| 2018 |
Agle K, Vincent BG, Piper C, Belle L, Zhou V, Shlomchik W, Serody JS, Drobyski WR. Bim regulates the survival and suppressive capability of CD8 FOXP3 regulatory T cells during murine GVHD. Blood. PMID 29769260 DOI: 10.1182/Blood-2017-09-807156 |
0.67 |
|
| 2018 |
Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS, Vincent BG, Wang AZ. A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e1706098. PMID 29691900 DOI: 10.1002/Adma.201706098 |
0.814 |
|
| 2018 |
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Serody JS, et al. The Immune Landscape of Cancer. Immunity. PMID 29628290 DOI: 10.1016/J.Immuni.2018.03.023 |
0.637 |
|
| 2018 |
Beckford Vera DR, Smith CC, Bixby LM, Glatt DM, Dunn SS, Saito R, Kim WY, Serody JS, Vincent BG, Parrott MC. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors. Plos One. 13: e0193832. PMID 29513764 DOI: 10.1371/Journal.Pone.0193832 |
0.818 |
|
| 2018 |
Zeidner JF, Vincent BG, Ivanova A, Foster MC, Coombs CC, Jamieson K, Van Deventer HW, Blanchard L, Frank C, Gallagher S, Matson M, Pepin K, Vaught L, Vogler N, Miller K, ... ... Serody JS, et al. Genomics Reveal Potential Biomarkers of Response to Pembrolizumab after High Dose Cytarabine in an Ongoing Phase II Trial in Relapsed/Refractory AML Blood. 132: 4054-4054. DOI: 10.1182/Blood-2018-99-116608 |
0.435 |
|
| 2018 |
Grover NS, Park SI, Ivanova A, Eldridge P, McKay K, Cheng CJA, Laing S, Covington D, West J, Sharf SE, Morrison JK, Scott S, Crecelius E, Shelley D, Alexander M, ... ... Serody JS, et al. Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin Blood. 132: 681-681. DOI: 10.1182/Blood-2018-99-113534 |
0.355 |
|
| 2017 |
Pearce OMT, Delaine-Smith R, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR, Montfort A, Dowe T, Gribben J, Jones JL, Kocher HM, ... Serody JS, et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discovery. PMID 29196464 DOI: 10.1158/2159-8290.Cd-17-0284 |
0.623 |
|
| 2017 |
Zhang S, Takaku M, Zou L, Gu AD, Chou WC, Zhang G, Wu B, Kong Q, Thomas SY, Serody JS, Chen X, Xu X, Wade PA, Cook DN, Ting JPY, et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature. PMID 29072299 DOI: 10.1038/Nature24283 |
0.431 |
|
| 2017 |
Gartlan KH, Bommiasamy H, Paz K, Wilkinson AN, Owen M, Reichenbach DK, Banovic T, Wehner K, Buchanan F, Varelias A, Kuns RD, Chang K, Fedoriw Y, Shea T, Coghill J, ... ... Serody JS, et al. A Critical Role for Donor-Derived IL-22 in Cutaneous Chronic GVHD. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 28941323 DOI: 10.1111/ajt.14513 |
0.32 |
|
| 2017 |
Poe JC, Jia W, Su H, Anand S, Rose JJ, Tata PV, Suthers AN, Jones CD, Kuan PF, Vincent BG, Serody JS, Horwitz ME, Ho VT, Pavletic SZ, Hakim FT, et al. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. Blood. PMID 28851699 DOI: 10.1182/Blood-2017-05-782466 |
0.669 |
|
| 2017 |
Taylor NA, Vick SC, Iglesia MD, Brickey WJ, Midkiff BR, McKinnon KP, Reisdorf S, Anders CK, Carey LA, Parker JS, Perou CM, Vincent BG, Serody JS. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer. The Journal of Clinical Investigation. PMID 28825599 DOI: 10.1172/Jci90499 |
0.683 |
|
| 2017 |
Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. PMID 28650437 DOI: 10.1038/Nnano.2017.113 |
0.655 |
|
| 2017 |
Forcade E, Paz K, Flynn R, Griesenauer B, Amet T, Li W, Liu L, Bakoyannis G, Jiang D, Chu HW, Lobera M, Yang J, Wilkes DS, Du J, Gartlan K, ... ... Serody JS, et al. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition. Jci Insight. 2. PMID 28614794 DOI: 10.1172/Jci.Insight.92111 |
0.523 |
|
| 2017 |
Ferrara JL, Smith CM, Sheets J, Reddy P, Serody JS. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. The Journal of Clinical Investigation. PMID 28581444 DOI: 10.1172/Jci90592 |
0.429 |
|
| 2017 |
Dant TA, Lin KL, Bruce DW, Montgomery SA, Kolupaev OV, Bommiasamy H, Bixby LM, Woosley JT, McKinnon KP, Gonzalez FJ, Blazar BR, Vincent BG, Coghill JM, Serody JS. T cell expression of AhR inhibits the maintenance of pTreg cells in the GI tract in acute GvHD. Blood. PMID 28550042 DOI: 10.1182/Blood-2016-08-734244 |
0.753 |
|
| 2017 |
Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, Armistead PM, Ting JP, Woosley JT, Blazar BR, Zaiss DM, ... ... Serody JS, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 28375154 DOI: 10.1172/Jci91816 |
0.765 |
|
| 2017 |
Faruki H, Mayhew GM, Serody JS, Hayes DN, Perou CM, Lai-Goldman M. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28341226 DOI: 10.1016/J.Jtho.2017.03.010 |
0.32 |
|
| 2017 |
Du J, Paz K, Flynn R, Vulic A, Robinson TM, Lineburg KE, Alexander KA, Meng J, Roy S, Panoskaltsis-Mortari A, Loschi M, Hill GR, Serody JS, Maillard I, Miklos D, et al. Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-β production. Blood. PMID 28254742 DOI: 10.1182/Blood-2017-01-758854 |
0.436 |
|
| 2017 |
Fowler KA, Jania CM, Tilley SL, Panoskaltsis-Mortari A, Baldwin AS, Serody JS, Coghill JM. Targeting the Canonical NF-κB Pathway with a High Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28161607 DOI: 10.1016/J.Bbmt.2017.01.083 |
0.38 |
|
| 2017 |
Park SI, Serody JS, Shea TC, Grover NS, Ivanova A, Morrison K, Eldridge P, Mckay K, Cheng CJ, Covington D, Wehner K, Dotti G, Savoldo B. A phase 1b/2 study of CD30-specific chimeric antigen receptor T-cell (CAR-T) therapy in combination with bendamustine in patients with CD30+ Hodgkin and non-Hodgkin lymphoma. Journal of Clinical Oncology. 35: TPS3095-TPS3095. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps3095 |
0.392 |
|
| 2017 |
Vincent BG, Moore DT, Moore SG, Kaltman RD, Puhalla S, Gudena VK, Carey LA, Dees EC, Muss HB, Reeder-Hayes KE, Jolly TA, Serody JS, Anders CK. LCCC 1525: Combination immunotherapy with cyclophosphamide plus pembrolizumab in patients with advanced triple negative breast cancer (TNBC). Journal of Clinical Oncology. 35: TPS1125-TPS1125. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps1125 |
0.376 |
|
| 2017 |
Xing Y, Stefanski H, Bruce DW, Hippen KL, Coghill JM, McKinnon K, Reisdorf S, Blazar B, Serody JS. A Novel Process for the Expansion of Functional Human ILC2 Cells for GCHD Prevention Blood. 130: 4432-4432. DOI: 10.1182/Blood.V130.Suppl_1.4432.4432 |
0.393 |
|
| 2017 |
Zeidner JF, Vincent BG, Ivanova A, Foster M, Coombs CC, Jamieson K, Deventer HV, Scibilia R, Blanchard L, Frank C, Gallagher S, Matson M, Pepin K, Vaught L, Vogler N, ... ... Serody JS, et al. Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Blood. 130: 1349-1349. DOI: 10.1182/Blood.V130.Suppl_1.1349.1349 |
0.35 |
|
| 2017 |
Vick SC, Taylor NA, Iglesia MD, Brickey WJ, Carey LA, Midkiff BR, McKinnon KP, Reisdorf S, Parker JS, Perou CM, Vincent BG, Serody JS. Abstract 568: Regulatory T cell recruitment limits the effectiveness of checkpoint inhibition for claudin-low breast cancer Immunology. 77: 568-568. DOI: 10.1158/1538-7445.Am2017-568 |
0.377 |
|
| 2017 |
Smith CC, Saito R, Bixby LM, Utsumi T, Kardos J, Chai S, Wobker SE, Krishnan B, Damrauer JS, Serody JS, Darr D, Vincent BG, Kim WY. Abstract 1654: Development of subtype specific mouse models of bladder cancer Cancer Research. 77: 1654-1654. DOI: 10.1158/1538-7445.Am2017-1654 |
0.367 |
|
| 2017 |
Copeland AC, Wood WA, Shea TC, Moore DT, Sharf A, Armistead PM, Coghill J, Jamieson K, Kasow KA, Serody JS, Vincent BG, Riches ML. Retrospective Analysis of Survival after Allogeneic Bone Marrow Transplantation in Adult Patients with High-Risk Psychosocial Characteristics Biology of Blood and Marrow Transplantation. 23: S222-S223. DOI: 10.1016/J.Bbmt.2016.12.394 |
0.312 |
|
| 2017 |
Armistead PM, Friend R, Xenakis J, Ivanova A, Serody JS, Gabriel D, Comeau T, Sarantopoulos S, Coghill J, Wood WA, Walko CM, Rao KV, Whitley J, Shea TC. Increased Immune Suppression is Associated with Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan Biology of Blood and Marrow Transplantation. 23: S261-S262. DOI: 10.1016/J.Bbmt.2016.12.158 |
0.431 |
|
| 2016 |
Wood WA, Krishnamurthy J, Mitin N, Torrice C, Parker JS, Snavely AC, Shea TC, Serody JS, Sharpless NE. Chemotherapy and Stem Cell Transplantation Increase p16(INK4a) Expression, a Biomarker of T-cell Aging. Ebiomedicine. PMID 27591832 DOI: 10.1016/J.Ebiom.2016.08.029 |
0.435 |
|
| 2016 |
Mose LE, Selitsky SR, Bixby LM, Marron DL, Iglesia MD, Serody JS, Perou CM, Vincent BG, Parker JS. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer. Bioinformatics (Oxford, England). PMID 27559159 DOI: 10.1093/Bioinformatics/Btw526 |
0.603 |
|
| 2016 |
Zhou V, Agle K, Chen X, Beres A, Komorowski R, Belle L, Taylor C, Zhu F, Haribhai D, Williams CB, Verbsky J, Blumenschein W, Sadekova S, Bowman E, Ballantyne C, ... ... Serody J, et al. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 27500496 DOI: 10.1172/Jci80874 |
0.696 |
|
| 2016 |
McDonald-Hyman C, Flynn R, Panoskaltsis-Mortari A, Peterson N, MacDonald KP, Hill GR, Luznik L, Serody JS, Murphy WJ, Maillard I, Munn DH, Turka LA, Koreth J, Cutler CS, Soiffer RJ, et al. Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5 dependent manner. Blood. PMID 27385791 DOI: 10.1182/Blood-2016-05-715896 |
0.458 |
|
| 2016 |
Montfort A, Pearce OM, Maniati E, Vincent B, Bixby LM, Böhm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, et al. A strong B cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27354470 DOI: 10.1158/1078-0432.Ccr-16-0081 |
0.693 |
|
| 2016 |
Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types. Journal of the National Cancer Institute. 108. PMID 27335052 DOI: 10.1093/Jnci/Djw144 |
0.643 |
|
| 2016 |
Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN, Kean LS, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, ... ... Serody JS, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. The Journal of Clinical Investigation. PMID 27294527 DOI: 10.1172/Jci85796 |
0.674 |
|
| 2016 |
Billard MJ, Fitzhugh DJ, Parker JS, Brozowski JM, McGinnis MW, Timoshchenko RG, Serafin DS, Lininger R, Klauber-Demore N, Sahagian G, Truong YK, Sassano MF, Serody JS, Tarrant TK. G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis. Plos One. 11: e0152856. PMID 27049755 DOI: 10.1371/Journal.Pone.0152856 |
0.345 |
|
| 2016 |
Faruki H, Mayhew G, Hayes DN, Serody JS, Perou CM, Lai-Goldman M. Immune cell activation among lung adenocarcinoma and squamous cell carcinoma intrinsic subtypes and CD274 (PD-L1) expression. Journal of Clinical Oncology. 34: 3077-3077. DOI: 10.1200/Jco.2016.34.15_Suppl.3077 |
0.34 |
|
| 2016 |
Du J, Flynn RP, Paz K, Vulic A, Robinson TM, Lineburg KE, Macdonald KPA, Hill GR, Serody JS, Maillard I, Panoskaltsis-Mortari A, Schacker T, Luznik L, Blazar BR. Pirfenidone Reverses Murine Chronic Graft Versus Host Disease Blood. 128: 1158-1158. DOI: 10.1182/Blood.V128.22.1158.1158 |
0.444 |
|
| 2016 |
Bruce DW, Stefanski HE, Vincent BG, Dant T, Reisdorf S, Bommiasamy H, Serody D, Wilson JE, McKinnon K, Shlomchik WD, Armistead PM, Ting JP, Woosley JT, Zaiss DM, Blazar BR, ... ... Serody JS, et al. Mechanism and Activity of ILC2 Cells Post Allo-BMT Blood. 128: 1155-1155. DOI: 10.1182/Blood.V128.22.1155.1155 |
0.494 |
|
| 2015 |
Serody J. GVHD and miR: good things in small packages. Blood. 126: 1265-7. PMID 26359430 DOI: 10.1182/Blood-2015-07-657114 |
0.354 |
|
| 2015 |
Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, Munn DH, Murphy WJ, Brickey WJ, Serody JS, Gabrilovich DI, Bronte V, Murray PJ, Ting JP, Zeiser R, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 126: 1621-8. PMID 26265697 DOI: 10.1182/Blood-2015-03-634691 |
0.606 |
|
| 2015 |
Shea TC, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 2129-35. PMID 26210442 DOI: 10.1016/J.Bbmt.2015.07.016 |
0.334 |
|
| 2015 |
Flynn R, Allen JL, Luznik L, MacDonald KP, Paz K, Alexander KA, Vulic A, Du J, Panoskaltsis-Mortari A, Taylor PA, Poe JC, Serody JS, Murphy WJ, Hill GR, Maillard I, et al. Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease. Blood. 125: 4085-94. PMID 25852057 DOI: 10.1182/Blood-2014-08-595470 |
0.468 |
|
| 2015 |
Veenstra RG, Flynn R, Kreymborg K, McDonald-Hyman C, Saha A, Taylor PA, Osborn MJ, Panoskaltsis-Mortari A, Schmitt-Graeff A, Lieberknect E, Murphy WJ, Serody JS, Munn DH, Freeman GJ, Allison JP, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 125: 3335-46. PMID 25814530 DOI: 10.1182/Blood-2014-09-603357 |
0.47 |
|
| 2015 |
Hunsucker SA, McGary CS, Vincent BG, Enyenihi AA, Waugh JP, McKinnon KP, Bixby LM, Ropp PA, Coghill JM, Wood WA, Gabriel DA, Sarantopoulos S, Shea TC, Serody JS, Alatrash G, et al. Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. Cancer Immunology Research. 3: 228-35. PMID 25576336 DOI: 10.1158/2326-6066.Cir-14-0001 |
0.769 |
|
| 2015 |
McDonald-Hyman C, Thangavelu G, Muller J, Zhang G, Kumari S, Saha A, Koehn BH, Mitchell JS, Fife BT, Serody JS, Osborn MJ, Hippen KL, Kelekar A, Munn DH, Altman A, et al. Protein Kinase C-Theta Interacts with mTORC2 and Vimentin to Limit Regulatory T-Cell Function Blood. 126: 849-849. DOI: 10.1182/Blood.V126.23.849.849 |
0.47 |
|
| 2015 |
Reisdorf S, Bommiasamy H, West M, Serody D, Bruce D, Vincent BG, Coghill J, Serody JS. Effect of Anti-Fungal Prophylaxis on the Fungal Mycobiome after Allogeneic Bone Marrow Transplantation Blood. 126: 4290-4290. DOI: 10.1182/Blood.V126.23.4290.4290 |
0.474 |
|
| 2015 |
Friend R, Xenakis J, Serody JS, Comeau T, Gabriel DA, Sarantopoulos S, Coghill J, Wood WA, Sharf A, Whitley JS, Rao K, Walko CM, Ivanova A, Shea TC, Armistead PM. Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306 Blood. 126: 3117-3117. DOI: 10.1182/Blood.V126.23.3117.3117 |
0.361 |
|
| 2015 |
Kolupaev O, West M, Blazar BR, Tilley S, Coghill J, Serody JS. Chronic GvHD Is Characterized By Impaired B Cell Development in the Bone Marrow Blood. 126: 1883-1883. DOI: 10.1182/Blood.V126.23.1883.1883 |
0.494 |
|
| 2015 |
Dant T, Bruce D, Fulton L, West M, Foger N, Serody JS. Absence of Coronin 1B in Donor T Cells Diminishes Acute Gvhd By Impairing T Cell Accumulation in Secondary Lymphoid Tissue Blood. 126: 1880-1880. DOI: 10.1182/Blood.V126.23.1880.1880 |
0.535 |
|
| 2015 |
Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, Burrill JS, Guo L, Sacristan C, Furlan SN, ... ... Serody JS, et al. Loss of Programmed Death Ligand-1 Expression on Donor T Cells Lessens Acute Graft-Versus-Host Disease Lethality Blood. 126: 147-147. DOI: 10.1182/Blood.V126.23.147.147 |
0.44 |
|
| 2015 |
Iglesia MD, Vincent BG, Serody JS, Carey LA, Barry WT, Sikov WM, Hudis CA, Winer EM, Perou CM. Abstract PD1-2: Impact of tumor-infiltrating B-cell clonal diversity on response to neoadjuvant therapy in triple negative and HER2+ breast cancer treated on CALGB (Alliance) 40601 and 40603 Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-Pd1-2 |
0.401 |
|
| 2015 |
Shea TC, Walko CM, Chung Y, Ivanova A, Rao KV, Coghill J, Sarantopoulos S, Wood WA, Armistead P, Gabriel DA, Serody JS. Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease Biology of Blood and Marrow Transplantation. 21: S310. DOI: 10.1016/J.Bbmt.2014.11.494 |
0.338 |
|
| 2014 |
Dubovsky JA, Flynn R, Du J, Harrington BK, Zhong Y, Kaffenberger B, Yang C, Towns WH, Lehman A, Johnson AJ, Muthusamy N, Devine SM, Jaglowski S, Serody JS, Murphy WJ, et al. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. The Journal of Clinical Investigation. 124: 4867-76. PMID 25271622 DOI: 10.1172/Jci75328 |
0.523 |
|
| 2014 |
Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, Lor M, Raffelt NC, Koyama M, Leveque L, Le Texier L, Melino M, Markey KA, Varelias A, Engwerda C, ... Serody JS, et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. The Journal of Clinical Investigation. 124: 4266-80. PMID 25157821 DOI: 10.1172/Jci75935 |
0.374 |
|
| 2014 |
Lim MY, Alker AP, Califano S, Trembath DG, Alby K, Gilligan PH, Jamieson K, Serody JS, Shea TC. Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 25071136 DOI: 10.1200/Jco.2013.51.4042 |
0.376 |
|
| 2014 |
Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3818-29. PMID 24916698 DOI: 10.1158/1078-0432.Ccr-13-3368 |
0.647 |
|
| 2014 |
Flynn R, Du J, Veenstra RG, Reichenbach DK, Panoskaltsis-Mortari A, Taylor PA, Freeman GJ, Serody JS, Murphy WJ, Munn DH, Sarantopoulos S, Luznik L, Maillard I, Koreth J, Cutler C, et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood. 123: 3988-98. PMID 24820310 DOI: 10.1182/Blood-2014-03-562231 |
0.508 |
|
| 2014 |
Fulton LM, Taylor NA, Coghill JM, West ML, Föger N, Bear JE, Baldwin AS, Panoskaltsis-Mortari A, Serody JS. Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease. European Journal of Immunology. 44: 1662-71. PMID 24752751 DOI: 10.1002/Eji.201344155 |
0.802 |
|
| 2014 |
Chow E, Rao KV, Wood WA, Covington D, Armistead PM, Coghill J, Serody JS, Gabriel DA, Jamieson KJ, Park YA, Raval JS, Shea TC. Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1064-8. PMID 24704385 DOI: 10.1016/J.Bbmt.2014.03.023 |
0.4 |
|
| 2014 |
Allen JL, Tata PV, Fore MS, Wooten J, Rudra S, Deal AM, Sharf A, Hoffert T, Roehrs PA, Shea TC, Serody JS, Richards KL, Jagasia M, Lee SJ, Rizzieri D, et al. Increased BCR responsiveness in B cells from patients with chronic GVHD. Blood. 123: 2108-15. PMID 24532806 DOI: 10.1182/Blood-2013-10-533562 |
0.414 |
|
| 2014 |
Lin KL, Fulton LM, Berginski M, West ML, Taylor NA, Moran TP, Coghill JM, Blazar BR, Bear JE, Serody JS. Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood. 123: 1604-14. PMID 24415540 DOI: 10.1182/Blood-2013-09-526020 |
0.803 |
|
| 2014 |
Mango RL, Wu QP, West M, McCook EC, Serody JS, van Deventer HW. C-C chemokine receptor 5 on pulmonary mesenchymal cells promotes experimental metastasis via the induction of erythroid differentiation regulator 1. Molecular Cancer Research : McR. 12: 274-82. PMID 24197118 DOI: 10.1158/1541-7786.Mcr-13-0164 |
0.792 |
|
| 2014 |
Zanin-Zhorov A, Flynn R, Luznik L, Panoskaltsis-Mortari A, Jing D, Goodman K, Weiss J, Nyuydzefe M, Chen W, Serody JS, MacDonald KP, Hill GR, O'Shea J, Roche M, Weiss S, et al. A Selective and Potent Rock 2 Inhibitor (KD025) Decreases Human STAT3-Dependent IL-21 and IL-17 Production and Experimental Chronic Graft-Versus-Host Disease (cGVHD) Blood. 124: 540-540. DOI: 10.1182/Blood.V124.21.540.540 |
0.439 |
|
| 2014 |
Bruce D, West M, Dant TA, Panoskaltsis-Mortari A, Blazar BR, Coghill JM, Serody JS. Infusion of Ex Vivo Activated Donor Type 2 Innate Lymphoid Cells Inhibit Th1 Activity and Reduces Acute Graft-Versus-Host Disease Blood. 124: 538-538. DOI: 10.1182/Blood.V124.21.538.538 |
0.535 |
|
| 2014 |
Flynn RP, Goodman K, Qi J, Jing D, Panoskaltsis-Mortari A, Yi Z, Dong C, Liu X, MacDonald KPA, Hill GR, Serody JS, Murphy WJ, Luznik L, Maillard I, Koreth J, et al. Targeting BCL6 and Germinal Centers (GCs) in Chronic Graft-Versus-Host Disease (cGVHD) Using Direct and Epigenomic Therapies Blood. 124: 535-535. DOI: 10.1182/Blood.V124.21.535.535 |
0.496 |
|
| 2014 |
Bommiasamy H, West M, Stockinger B, Coghill JM, Serody JS. Plasticity of Th17 Cells and Conversion to Th1 Cells during Acute GvHD Blood. 124: 3821-3821. DOI: 10.1182/Blood.V124.21.3821.3821 |
0.51 |
|
| 2014 |
van Deventer HW, Voorhees PM, Serody JS. The Contribution of Fibrocytes to the Progression of Multiple Myeloma Blood. 124: 3411-3411. DOI: 10.1182/Blood.V124.21.3411.3411 |
0.377 |
|
| 2014 |
Dubovsky JA, Flynn R, Du J, Harrington BK, Zhong Y, Yang C, Towns W, Lehman A, Johnson A, Devine S, Jaglowski S, Serody JS, Murphy WJ, Munn DH, Luznik L, et al. Abstract 2591: Ibrutinib can reverse established chronic graft-versus-host disease, which is dependent upon IL-2 inducible T-cell kinase (ITK) and Bruton's tyrosine kinase (BTK)-driven lymphocyte activation Cancer Research. 74: 2591-2591. DOI: 10.1158/1538-7445.Am2014-2591 |
0.512 |
|
| 2013 |
Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, et al. Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood. 122: 2125-34. PMID 23814022 DOI: 10.1182/Blood-2012-11-470252 |
0.81 |
|
| 2013 |
Coghill JM, Fowler KA, West ML, Fulton LM, van Deventer H, McKinnon KP, Vincent BG, Lin K, Panoskaltsis-Mortari A, Cook DN, Blazar BR, Serody JS. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease. Blood. 122: 825-36. PMID 23798714 DOI: 10.1182/Blood-2012-06-435735 |
0.828 |
|
| 2013 |
Vincent BG, Serody JS. One is better than two: TCR pairing and GVHD. Science Translational Medicine. 5: 188fs21. PMID 23740895 DOI: 10.1126/Scitranslmed.3006431 |
0.683 |
|
| 2013 |
Wood WA, Deal AM, Reeve BB, Abernethy AP, Basch E, Mitchell SA, Shatten C, Hie Kim Y, Whitley J, Serody JS, Shea T, Battaglini C. Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study. Bone Marrow Transplantation. 48: 1342-9. PMID 23584437 DOI: 10.1038/Bmt.2013.58 |
0.3 |
|
| 2013 |
van Deventer HW, Palmieri DA, Wu QP, McCook EC, Serody JS. Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. Journal of Immunology (Baltimore, Md. : 1950). 190: 4861-7. PMID 23536638 DOI: 10.4049/Jimmunol.1202857 |
0.357 |
|
| 2013 |
Wood WA, Whitley J, Goyal R, Brown PM, Sharf A, Irons R, Rao KV, Essenmacher A, Serody JS, Coghill JM, Armistead PM, Sarantopoulos S, Gabriel DA, Shea TC. Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT. Bone Marrow Transplantation. 48: 771-6. PMID 23165501 DOI: 10.1038/Bmt.2012.216 |
0.32 |
|
| 2013 |
Kim GG, Zanation AM, Taylor NA, Shores CG, McKinnon KP, Serody JS. Significance of myeloid-derived suppressor cells in squamous cell carcinoma of the head and neck. Journal of Clinical Oncology. 31: 6070-6070. DOI: 10.1200/Jco.2013.31.15_Suppl.6070 |
0.317 |
|
| 2013 |
Allen JL, Tata PV, Wooten J, Fore MS, Deal AM, Sharf A, Hoffert T, Roehrs PA, Armistead PM, Coghill J, Wood WA, Shea TC, Serody J, Richards KL, Jagasia M, et al. BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406 Blood. 122: 910-910. DOI: 10.1182/Blood.V122.21.910.910 |
0.412 |
|
| 2013 |
Bommiasamy H, Ott L, West S, Fulton LM, Panoskaltsis-Mortari A, Blazar BR, Fouser L, Serody J. IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells Blood. 122: 4482-4482. DOI: 10.1182/Blood.V122.21.4482.4482 |
0.786 |
|
| 2013 |
Lin KL, Fulton LM, Serody J. Aryl Hydrocarbon Receptor Deficient Donor T Cells Display Decreased Migration and Cause Reduced Or Enhanced Graft-Versus-Host Diseases In Different Transplant Models Blood. 122: 4477-4477. DOI: 10.1182/Blood.V122.21.4477.4477 |
0.816 |
|
| 2013 |
Flynn R, Du J, Veenstra R, Panoskaltsis-Mortari A, Price A, Taylor PA, Freeman GJ, Browning JL, Serody J, Murphy WJ, Munn D, Sarantopoulos S, Luznik L, Maillard I, Koreth J, et al. Germinal Center Generation and Maintenance By T Follicular Helper Cells Is Required For The Development Of Chronic Gvhd Associated Bronchiolitis Obliterans In a Preclinical Model Blood. 122: 292-292. DOI: 10.1182/Blood.V122.21.292.292 |
0.552 |
|
| 2013 |
Tata PV, Vincent BG, Kuan P, Jones C, Serody J, Sarantopoulos S. High-Throughput Immunoglobulin Heavy Chain Variable Region Repertoire Analysis Of CD27+ B Cell Subsets From Patients With Chronic Gvhd Blood. 122: 2055-2055. DOI: 10.1182/Blood.V122.21.2055.2055 |
0.393 |
|
| 2013 |
Wood WA, Deal AM, Abernethy A, Battaglini C, Kim YH, Whitley J, Shatten C, Serody JS, Shea TC, Reeve BB. Feasibility of Cardiopulmonary Exercise Testing and Longitudinal Patient-Reported Outcome (PRO) Assessment in Patients Undergoing Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 19: S221. DOI: 10.1016/J.Bbmt.2012.11.262 |
0.32 |
|
| 2013 |
Allen JL, Fedoriw G, Wooten J, Fore M, Roehrs PA, Armistead P, Coghill J, Shea TC, Richards K, Lee SJ, Rowe K, Rizzieri D, Chao NJ, Serody JS, Sarantopoulos S. Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets Biology of Blood and Marrow Transplantation. 19: S136-S137. DOI: 10.1016/J.Bbmt.2012.11.075 |
0.38 |
|
| 2012 |
Allen JL, Fore MS, Wooten J, Roehrs PA, Bhuiya NS, Hoffert T, Sharf A, Deal AM, Armistead P, Coghill J, Gabriel DA, Irons R, Essenmacher A, Shea TC, Richards K, ... ... Serody J, et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood. 120: 2529-36. PMID 22896003 DOI: 10.1182/Blood-2012-06-438911 |
0.412 |
|
| 2012 |
Fulton LM, Carlson MJ, Coghill JM, Ott LE, West ML, Panoskaltsis-Mortari A, Littman DR, Blazar BR, Serody JS. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt. Journal of Immunology (Baltimore, Md. : 1950). 189: 1765-72. PMID 22778391 DOI: 10.4049/Jimmunol.1200858 |
0.813 |
|
| 2012 |
Serody J. Bacterial sepsis and GI tract GVHD: more commensal than you think. Blood. 120: 6-7. PMID 22767576 DOI: 10.1182/Blood-2012-05-427435 |
0.325 |
|
| 2012 |
Fedoriw Y, Samulski TD, Deal AM, Dunphy CH, Sharf A, Shea TC, Serody JS, Sarantopoulos S. Bone marrow B cell precursor number after allogeneic stem cell transplantation and GVHD development. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 968-73. PMID 22446015 DOI: 10.1016/J.Bbmt.2012.03.005 |
0.436 |
|
| 2012 |
Serody JS, Hill GR. The IL-17 differentiation pathway and its role in transplant outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: S56-61. PMID 22226114 DOI: 10.1016/J.Bbmt.2011.10.001 |
0.377 |
|
| 2012 |
Wood WA, Deal AM, Battaglini CL, Reeve BB, Abernethy AP, Kim YH, Whitley JS, Shatten C, Irons RN, Essenmacher AN, Wehner K, Pinto A, Coghill J, Armistead PM, Sarantopoulos S, ... ... Serody JS, et al. Feasibility and Prognostic Value of VO2peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT) Blood. 120: 4152-4152. DOI: 10.1182/Blood.V120.21.4152.4152 |
0.312 |
|
| 2012 |
Vincent BG, Singh D, Wu M, Hunsucker SA, Alatrash G, Ruisaard K, Sukhumalchandra P, Clise-Dwyer K, Serody JS, Prins JF, Molldrem JJ, Armistead PM. RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants. Blood. 120: 2502-2502. DOI: 10.1182/Blood.V120.21.2502.2502 |
0.324 |
|
| 2012 |
Wu QP, Serody JS, Deventer HWv. Abstract 1533: Fibrocytes promote metastasis by recruiting Ly-6C+ myeloid cells Cancer Research. 72: 1533-1533. DOI: 10.1158/1538-7445.Am2012-1533 |
0.427 |
|
| 2011 |
Wood W, Deal A, Whitley J, Sharf A, Serody J, Gabriel D, Shea T. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant. Pediatric Blood & Cancer. 57: 499-505. PMID 21384538 DOI: 10.1002/Pbc.23057 |
0.359 |
|
| 2011 |
Beaven AW, Moore DT, Sharf A, Serody JS, Shea TC, Gabriel DA. Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma. Cancer Investigation. 29: 214-9. PMID 21314330 DOI: 10.3109/07357907.2010.550663 |
0.358 |
|
| 2011 |
Coghill JM, Sarantopoulos S, Moran TP, Murphy WJ, Blazar BR, Serody JS. Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood. 117: 3268-76. PMID 21245483 DOI: 10.1182/Blood-2010-12-290403 |
0.505 |
|
| 2011 |
Lin KL, West ML, Coghill J, Jones S, Bear JE, Serody JS. In Vivo Assessment of T Effector, T Regulatory Cell, Dendritic Cell Interaction in Lymphoid Tissue Using Intravital Imaging During Acute GvHD Blood. 118: 818-818. DOI: 10.1182/Blood.V118.21.818.818 |
0.526 |
|
| 2011 |
Fulton LM, Coghill J, West ML, Foger N, Bear J, Serody JS. Impaired Donor T Cell Egress From Recipient Lymphoid Tissue Profoundly Diminishes Acute GvHD, Blood. 118: 4022-4022. DOI: 10.1182/Blood.V118.21.4022.4022 |
0.806 |
|
| 2011 |
Wood WA, Whitley J, Goyal RK, Brown PM, Sharf A, Irons RN, Rao K, Essenmacher AN, Serody J, Coghill J, Armistead PM, Sarantopoulos S, Gabriel DA, Shea TC. Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma Blood. 118: 2083-2083. DOI: 10.1182/Blood.V118.21.2083.2083 |
0.328 |
|
| 2011 |
van Deventer HW, Hoffert T, West ML, Wu QP, Serody JS. Bone Marrow Stromal Cells Inhibit Apoptosis of Chronic Lymphocytic Leukemia Cells (CLL) by Expressing Erythroid Differentiation Regulator 1 (ERDR1) Blood. 118: 1764-1764. DOI: 10.1182/Blood.V118.21.1764.1764 |
0.437 |
|
| 2010 |
van Deventer HW, Burgents JE, Wu QP, Woodford RM, Brickey WJ, Allen IC, McElvania-Tekippe E, Serody JS, Ting JP. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. Cancer Research. 70: 10161-9. PMID 21159638 DOI: 10.1158/0008-5472.Can-10-1921 |
0.809 |
|
| 2010 |
Carlson MJ, Fulton LM, Coghill JM, West ML, Burgents JE, Wan Y, Panoskaltsis-Mortari A, Tedder TF, Blazar BR, Serody JS. L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10: 2596-603. PMID 21070606 DOI: 10.1111/J.1600-6143.2010.03319.X |
0.812 |
|
| 2010 |
Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, Taylor PA, Panoskaltsis-Mortari A, Serody JS, Munn DH, Tolar J, Ochoa AC, Blazar BR. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 116: 5738-47. PMID 20807889 DOI: 10.1182/Blood-2010-06-287839 |
0.408 |
|
| 2010 |
Wood WA, Whitley J, Moore D, Sharf A, Irons R, Rao K, Serody J, Coghill J, Gabriel D, Shea T. Chemomobilization with Etoposide is Highly Effective in Patients with Multiple Myeloma and Overcomes the Effects of Age and Prior Therapy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 141-6. PMID 20637882 DOI: 10.1016/J.Bbmt.2010.06.021 |
0.344 |
|
| 2010 |
Burgents JE, Moran TP, West ML, Davis NL, Johnston RE, Serody JS. The immunosuppressive tumor environment is the major impediment to successful therapeutic vaccination in Neu transgenic mice. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 482-91. PMID 20463599 DOI: 10.1097/Cji.0B013E3181D756Bb |
0.769 |
|
| 2010 |
Coghill JM, Carlson MJ, Panoskaltsis-Mortari A, West ML, Burgents JE, Blazar BR, Serody JS. Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells. Blood. 115: 4914-22. PMID 20185583 DOI: 10.1182/Blood-2009-08-239848 |
0.811 |
|
| 2010 |
Coghill JM, West ML, Cook DN, Serody JS. The Absence of CC-Chemokine Receptor 8 on Donor Regulatory T Cells Impairs Their Ability to Prevent Lethal Acute Gvhd. Blood. 116: 3743-3743. DOI: 10.1182/Blood.V116.21.3743.3743 |
0.527 |
|
| 2010 |
Fulton LM, Carlson MJ, Coghill J, West ML, Panoskaltisis-Mortari A, Blazar BR, Littman D, Serody J. Attenuated Acute Graft-Versus-Host Disease Following Allogeneic Stem Cell Transplantation In the Absence of RORγt. Blood. 116: 3742-3742. DOI: 10.1182/Blood.V116.21.3742.3742 |
0.802 |
|
| 2010 |
Wooten J, Nazmim BS, Richards K, Sharf A, Antin JH, Soiffer RJ, Ritz J, Shea TC, Serody J, Baldwin AS, Sarantopoulos S. B Cells Are Primed for Survival by BAFF-Driven Bim Degradation In Chronic Graft Versus Host Disease (cGVHD) Patients Blood. 116: 216-216. DOI: 10.1182/Blood.V116.21.216.216 |
0.435 |
|
| 2010 |
Van Deventer HW, Mango R, Serody J. Erythroid Differentiation Regulator 1 (ERDR1) From Nurse-Like Cells Promotes the Survival of Chronic Lymphocytic Leukemia Cells Blood. 116: 1372-1372. DOI: 10.1182/Blood.V116.21.1372.1372 |
0.808 |
|
| 2009 |
Shea TC, Beaven AW, Moore DT, Serody JS, Gabriel DA, Chao N, Gockerman JP, Garcia RA, Rizzieri DA. Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival. Leukemia & Lymphoma. 50: 741-8. PMID 19358012 DOI: 10.1080/10428190902853136 |
0.364 |
|
| 2009 |
Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood. 113: 1365-74. PMID 18957685 DOI: 10.1182/Blood-2008-06-162420 |
0.457 |
|
| 2009 |
Wood WA, Whitley J, Moore DT, Serody JS, Gabriel DA, Coghill JM, Irons R, Shea TC. The Efficacy and Safety of VP-16 and G-CSF as a Mobilization Regimen Prior to Autologous Stem Cell Transplantation (ASCT) for Patients (Pts) with Multiple Myeloma (MM) and Lymphoma. Blood. 114: 4225-4225. DOI: 10.1182/Blood.V114.22.4225.4225 |
0.355 |
|
| 2009 |
Mango RL, van Deventer HW, Wu QP, Serody JS. Pulmonary Stromal Cells Expressing CC-Chemokine Receptor 5 Promote Metastasis Via Erythroid Differentiation Regulator 1. Blood. 114: 3601-3601. DOI: 10.1182/Blood.V114.22.3601.3601 |
0.805 |
|
| 2009 |
Carlson MJ, Coghill JM, West ML, Panoskaltsis-Mortari A, Blazar BR, Serody JS. CCR1 Is Required for Treg-Mediated Protection From Lethal Acute Graft-Versus-Host Disease. Blood. 114: 1337-1337. DOI: 10.1182/Blood.V114.22.1337.1337 |
0.529 |
|
| 2008 |
Coghill JM, Carlson MJ, Moran TP, Serody JS. The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting. Leukemia & Lymphoma. 49: 1860-9. PMID 18661393 DOI: 10.1080/10428190802272684 |
0.477 |
|
| 2008 |
Taylor PA, Ehrhardt MJ, Lees CJ, Panoskaltsis-Mortari A, Krieg AM, Sharpe AH, Murphy WJ, Serody JS, Hemmi H, Akira S, Levy RB, Blazar BR. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood. 112: 3508-16. PMID 18614760 DOI: 10.1182/Blood-2007-09-113670 |
0.452 |
|
| 2008 |
van Deventer HW, Wu QP, Bergstralh DT, Davis BK, O'Connor BP, Ting JP, Serody JS. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. The American Journal of Pathology. 173: 253-64. PMID 18535183 DOI: 10.2353/Ajpath.2008.070732 |
0.565 |
|
| 2008 |
Coghill JM, Hogan KN, Serody JS. The Absence of CCR7 on Donor T Cells Leads to Attenuated Graft-Versus- Host Disease (GVHD) with a Preserved Graft-Versus-Leukemia (GVL) Effect Blood. 112: 810-810. DOI: 10.1182/Blood.V112.11.810.810 |
0.521 |
|
| 2008 |
Coghill JM, Nograles KE, Krueger JG, Coghill AS, Serody JS, Ivanova A, Whitley J, Gabriel D, Comeau T, Shea T. Adhesion Molecule Blockade with the Humanized Anti-LFA-1 Monoclonal Antibody Efalizumab Improves Steroid Refractory Acute and Chronic Graft-Versus-Host Disease of the Skin Blood. 112: 4350-4350. DOI: 10.1182/Blood.V112.11.4350.4350 |
0.419 |
|
| 2008 |
Serody J, Wysocki CA, Moran TP. Recruitment of Donor T Cells to Secondary Lymphoid Tissue Is Enhanced by Conditioning Therapy and Donor T Cells/Marrow Blood. 112: 3506-3506. DOI: 10.1182/Blood.V112.11.3506.3506 |
0.516 |
|
| 2007 |
Petermann KB, Rozenberg GI, Zedek D, Groben P, McKinnon K, Buehler C, Kim WY, Shields JM, Penland S, Bear JE, Thomas NE, Serody JS, Sharpless NE. CD200 is induced by ERK and is a potential therapeutic target in melanoma. The Journal of Clinical Investigation. 117: 3922-9. PMID 18008004 DOI: 10.1172/Jci32163 |
0.413 |
|
| 2007 |
Moran TP, Burgents JE, Long B, Ferrer I, Jaffee EM, Tisch RM, Johnston RE, Serody JS. Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice. Vaccine. 25: 6604-12. PMID 17675184 DOI: 10.1016/J.Vaccine.2007.06.058 |
0.767 |
|
| 2007 |
Taylor PA, Ehrhardt MJ, Lees CJ, Tolar J, Weigel BJ, Panoskaltsis-Mortari A, Serody JS, Brinkmann V, Blazar BR. Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood. 110: 3480-8. PMID 17606761 DOI: 10.1182/Blood-2007-05-087940 |
0.516 |
|
| 2007 |
Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS, Blazar BR. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 109: 1307-15. PMID 17018854 DOI: 10.1182/Blood-2006-05-022772 |
0.508 |
|
| 2007 |
Shea T, Serody J, Gabriel D, Comeau T, Ivanova A, Moore D, Irons R, Julia W, Andrew S, Dunphy C, Mark B. Low Incidence of GVHD and Treatment-Related Morbidity (TRM) with Intermediate Doses of Continuous Infusion IV Busulfan and Daily Fludarabine with Individualized Doses of Alemtuzamab for Matched Related (MRD) and Unrelated (MUD) Transplant Pts with High-Risk Hematologic Malignancies. Blood. 110: 4940-4940. DOI: 10.1182/Blood.V110.11.4940.4940 |
0.309 |
|
| 2007 |
Buie LW, Rao KV, Epstein S, Shea TC, Comeau T, Gabriel DA, Irons R, Eron B, Serody J. Symptomatic Improvement Following Intravesicular Cidofovir for the Management of BK Virus Associated Cystitis. Blood. 110: 3007-3007. DOI: 10.1182/Blood.V110.11.3007.3007 |
0.357 |
|
| 2007 |
Carlson MJ, Siedel HE, Serody JS. CD62L Is Not Critical for T Regulatory Cell-Mediated Protection from Lethal Acute GVHD. Blood. 110: 2178-2178. DOI: 10.1182/Blood.V110.11.2178.2178 |
0.492 |
|
| 2007 |
Coghill JM, Seidel H, Serody JS. Absence of CCR4 Enhances the Function of Expanded Regulatory T-Cells. Blood. 110: 2172-2172. DOI: 10.1182/Blood.V110.11.2172.2172 |
0.494 |
|
| 2007 |
Carlson MJ, Serody JS. TH17 Cells Mediate Extensive Skin Pathology in Acute GVHD. Blood. 110: 2166-2166. DOI: 10.1182/Blood.V110.11.2166.2166 |
0.469 |
|
| 2006 |
Gilman AL, Serody J. Diagnosis and treatment of chronic graft-versus-host disease. Seminars in Hematology. 43: 70-80. PMID 16412791 DOI: 10.1053/J.Seminhematol.2005.09.008 |
0.391 |
|
| 2006 |
Taylor PA, Ehrhardt MJ, Panoskaltsis-Mortari A, Serody JS, Brinkmann V, Blazar BR. FTY720 Inhibits Graft-Versus-Host Disease (GVHD) and Allogeneic Bone Marrow (BM) Graft Rejection Independent of Effects on T Cell Egress from Lymphoid Tissue. Blood. 108: 450-450. DOI: 10.1182/Blood.V108.11.450.450 |
0.498 |
|
| 2006 |
Blazar BR, Panoskaltsis-Mortari A, Krieg AM, Hemmi H, Akira S, Serody J, Murphy WJ, Taylor PA. In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs. Blood. 108: 446-446. DOI: 10.1182/Blood.V108.11.446.446 |
0.465 |
|
| 2006 |
Taylor PA, Ehrhardt MJ, Roforth MM, Swedin JM, Panoskaltsis-Mortari A, Serody JS, Blazar BR. Mechanisms Responsible for and Strategies To Overcome Bone Marrow (BM) Rejection in Allosensitized Recipients. Blood. 108: 3212-3212. DOI: 10.1182/Blood.V108.11.3212.3212 |
0.439 |
|
| 2006 |
Beaven AW, Comeau T, Sharf A, Moore DT, Serody J, Shea TC, Gabriel DA. Mitoxantrone and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplant for Multiple Myeloma. Blood. 108: 2945-2945. DOI: 10.1182/Blood.V108.11.2945.2945 |
0.343 |
|
| 2005 |
Gabriel DA, Shea TC, Serody JS, Moore DT, Kirby SL, Harvey D, Krasnov C. Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 1022-30. PMID 16338625 DOI: 10.1016/J.Bbmt.2005.08.033 |
0.359 |
|
| 2005 |
Moran TP, Collier M, McKinnon KP, Davis NL, Johnston RE, Serody JS. A novel viral system for generating antigen-specific T cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 3431-8. PMID 16116238 DOI: 10.4049/Jimmunol.175.5.3431 |
0.363 |
|
| 2005 |
Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L, Blazar BR, Serody JS. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood. 106: 3300-7. PMID 16002422 DOI: 10.1182/Blood-2005-04-1632 |
0.777 |
|
| 2005 |
van Deventer HW, O'Connor W, Brickey WJ, Aris RM, Ting JP, Serody JS. C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Research. 65: 3374-9. PMID 15833871 DOI: 10.1158/0008-5472.Can-04-2616 |
0.577 |
|
| 2005 |
Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood. 105: 4191-9. PMID 15701715 DOI: 10.1182/Blood-2004-12-4726 |
0.757 |
|
| 2005 |
Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, Rudensky AY, Mak TW, Serody JS, Blazar BR. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood. 105: 3372-80. PMID 15618467 DOI: 10.1182/Blood-2004-10-3869 |
0.566 |
|
| 2005 |
Hildebrandt GC, Olkiewicz KM, Choi S, Corrion LA, Clouthier SG, Liu C, Serody JS, Cooke KR. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood. 105: 2249-57. PMID 15546955 DOI: 10.1182/Blood-2004-08-3320 |
0.512 |
|
| 2005 |
Beaven AW, Shea TC, Gabriel DA, Comeau T, Irons R, Moore DT, Lin L, Sharf A, Krasnov C, Brecher ME, Serody J. Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant. Blood. 106: 5385-5385. DOI: 10.1182/Blood.V106.11.5385.5385 |
0.341 |
|
| 2005 |
Shea TC, Serody J, Gabriel D, Comeauu T, Morris D, Irons R, Harvey D, Sharf A, Krasnov C, Dunphy C, Banderenko N, Brecher M. High relapse rate following alemtuzamab use in allogeneic transplants for myeloid hematologic malignancies Biology of Blood and Marrow Transplantation. 11: 28-29. DOI: 10.1016/J.Bbmt.2004.12.082 |
0.334 |
|
| 2004 |
Blazar BR, Levy RB, Mak TW, Panoskaltsis-Mortari A, Muta H, Jones M, Roskos M, Serody JS, Yagita H, Podack ER, Taylor PA. CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. Journal of Immunology (Baltimore, Md. : 1950). 173: 2933-41. PMID 15322151 DOI: 10.4049/Jimmunol.173.5.2933 |
0.375 |
|
| 2004 |
Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL, June CH, Serody JS, Blazar BR. L-selectinhi but not the L-selectinlo CD4 +25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection Blood. 104: 3804-3812. PMID 15292057 DOI: 10.1182/Blood-2004-05-1850 |
0.523 |
|
| 2004 |
Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K, Blazar BR, Serody JS. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. Journal of Immunology (Baltimore, Md. : 1950). 173: 845-54. PMID 15240671 DOI: 10.4049/Jimmunol.173.2.845 |
0.786 |
|
| 2004 |
Dees EC, McKinnon KP, Kuhns JJ, Chwastiak KA, Sparks S, Myers M, Collins EJ, Frelinger JA, Van Deventer H, Collichio F, Carey LA, Brecher ME, Graham M, Earp HS, Serody JS. Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer. Cancer Immunology, Immunotherapy : Cii. 53: 777-85. PMID 15185007 DOI: 10.1007/S00262-004-0520-1 |
0.602 |
|
| 2004 |
Sun K, Welniak LA, Panoskaltsis-Mortari A, O'Shaughnessy MJ, Liu H, Barao I, Riordan W, Sitcheran R, Wysocki C, Serody JS, Blazar BR, Sayers TJ, Murphy WJ. Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib. Proceedings of the National Academy of Sciences of the United States of America. 101: 8120-5. PMID 15148407 DOI: 10.1073/Pnas.0401563101 |
0.776 |
|
| 2004 |
Panoskaltsis-Mortari A, Price A, Hermanson JR, Taras E, Lees C, Serody JS, Blazar BR. In vivo imaging of graft-versus-host-disease in mice. Blood. 103: 3590-8. PMID 14715632 DOI: 10.1182/Blood-2003-08-2827 |
0.447 |
|
| 2004 |
Taylor P, Panoskaltsis-Mortari A, Freeman G, Sharpe A, Noelle R, Rudensky A, Mak T, Serody J, Blazar B. The ICOS:ICOSL Costimulatory Pathway Plays an Important Role in GVHD and Bone Marrow (BM) Graft Rejection. Blood. 104: 591-591. DOI: 10.1182/Blood.V104.11.591.591 |
0.525 |
|
| 2004 |
Taylor P, Panoskaltsis-Mortari A, Noelle R, Rudensky A, Serody J, Blazar B. Visualizing Allogeneic Bone Marrow (BM) Graft Rejection. Blood. 104: 43-43. DOI: 10.1182/Blood.V104.11.43.43 |
0.529 |
|
| 2004 |
Shea TC, Serody J, Gabriel D, Comeau T, Harvey D, Irons R, Morris D, Sharf A, Krasnov C, Dunphy C, Banderenko N, Brecher M. High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies. Blood. 104: 1826-1826. DOI: 10.1182/Blood.V104.11.1826.1826 |
0.386 |
|
| 2004 |
Blazar B, Panoskaltsis-Mortari A, Levine B, June C, Lucas P, Gress R, Serody J, Taylor P. The role of CD4+CD25+ T regulatory (Treg) cells in allogeneic bone marrow transplantation Biology of Blood and Marrow Transplantation. 10: 737. DOI: 10.1016/J.Bbmt.2004.06.025 |
0.302 |
|
| 2003 |
Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Seminars in Oncology. 30: 76-83. PMID 14727245 DOI: 10.1053/J.Seminoncol.2003.11.040 |
0.321 |
|
| 2003 |
Shea TC, Bruner R, Wiley JM, Serody JS, Sailer S, Gabriel DA, Capel E, Moore DT, Dent G, Bentley S, Brecher ME. An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 9: 443-52. PMID 12869958 DOI: 10.1016/S1083-8791(03)00204-0 |
0.333 |
|
| 2003 |
Ng-Cashin J, Kuhns JJ, Burkett SE, Powderly JD, Craven RR, van Deventer HW, Kirby SL, Serody JS. Host absence of CCR5 potentiates dendritic cell vaccination. Journal of Immunology (Baltimore, Md. : 1950). 170: 4201-8. PMID 12682253 DOI: 10.4049/Jimmunol.170.8.4201 |
0.392 |
|
| 2003 |
Panoskaltsis-Mortari A, Hermanson JR, Taras E, Wangensteen OD, Serody JS, Blazar BR. Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice. Blood. 101: 3714-21. PMID 12511416 DOI: 10.1182/Blood-2002-08-2465 |
0.454 |
|
| 2000 |
Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, Lira SA, Cook DN, Blazar BR. T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease Blood. 96: 2973-2980. PMID 11049973 DOI: 10.1182/Blood.V96.9.2973.H8002973_2973_2980 |
0.434 |
|
| 2000 |
Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 6: 434-40. PMID 10975512 DOI: 10.1016/S1083-8791(00)70035-8 |
0.354 |
|
| 2000 |
Serody JS, Collins EJ, Tisch RM, Kuhns JJ, Frelinger JA. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery Journal of Immunology. 164: 4961-4967. PMID 10779807 DOI: 10.4049/Jimmunol.164.9.4961 |
0.556 |
|
| 2000 |
Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK, Lira SA, Cook DN, Blazar BR. T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease Blood. 96: 2973-2980. DOI: 10.1182/blood.v96.9.2973 |
0.343 |
|
| 1999 |
Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier Blood. 93: 43-50. DOI: 10.1182/blood.v93.1.43.401k24_43_50 |
0.598 |
|
| 1999 |
Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1 Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier Blood. 93: 43-50. DOI: 10.1182/Blood.V93.1.43 |
0.64 |
|
| 1998 |
Frelinger JA, Serody J. Immune response of β2-microglobulin-deficient mice to pathogens Current Topics in Microbiology and Immunology. 232: 99-114. PMID 9557395 DOI: 10.1007/978-3-642-72045-1_5 |
0.644 |
|
| 1997 |
Serody JS, Shea TC. Prevention of infections in bone marrow transplant recipients. Infectious Disease Clinics of North America. 11: 459-77. PMID 9187956 DOI: 10.1016/S0891-5520(05)70365-2 |
0.352 |
|
| 1997 |
Bentley SA, Brecher ME, Powell E, Serody JS, Wiley JM, Shea TC. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients Bone Marrow Transplantation. 19: 557-563. PMID 9085735 DOI: 10.1038/Sj.Bmt.1700717 |
0.353 |
|
| 1996 |
Serody JS, Poston RM, Weinstock D, Kurlander RJ, Frelinger JA. CD4+ cytolytic effecters are inefficient in the clearance of Listeria monocytogenes Immunology. 88: 544-550. PMID 8881755 DOI: 10.1046/J.1365-2567.1996.D01-698.X |
0.573 |
|
| 1996 |
Bandarenko NA, Brecher ME, Owen H, Wiley J, Shea T, Serody J. Thrombocytopenia In Allogeneic Peripheral Blood Stem Cell Collections Transfusion. 36: 668-669. PMID 8701463 DOI: 10.1046/J.1537-2995.1996.36796323066.X |
0.321 |
|
| 1993 |
Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 16: 54-8. PMID 8448319 DOI: 10.1093/Clinids/16.1.54 |
0.327 |
|
| Show low-probability matches. |